設為首頁  |  加入收藏
丹東總部:
地址:遼寧丹東市濱江中路64號
            佳地廣場B座1606室
郵編:118000
電話:+86 415 3458366
傳真:+86 415 2389688
郵箱:
zhengwm@ltndt.com
網址:
www.saffsuzukicup.com  
聯系人:鄭女士
QQ:721814853
北京辦:
地址:北京市大興區黃村鎮保利
            茉莉公館3號樓1單元
            1205室   
郵編:102600
電話:010-5602 4050
傳真:010-8025 7167

 

Varian Medical Systems Receives FDA 510(k) Clearance for Vitesse™ Brachytherapy Treatment Planning Software

Tool enables clinicians to plan and perform high-dose-rate (HDR) brachytherapy treatments for prostate cancer using real-time ultrasound guidance

Jan 24, 2013

PALO ALTO, Calif., Jan. 24, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) has received an FDA 510(k) clearance for the latest version of its Vitesse™ real time planning for HDR brachytherapy which is used to plan and perform high-dose-rate (HDR), ultrasound-guided brachytherapy treatments for prostate cancer. 

"This version of Vitesse reduces the number and complexity of steps involved in planning and completing a treatment. It eliminates the need for a data transfer to another software program, and avoids moving the patient to a CT scanner for images in the middle of the procedure. For these reasons, most clinicians will see a reduction in the amount of time needed to complete these treatments, often by as much as an hour and a half," said Tim Clark, marketing manager for Varian BrachyTherapy.

HDR brachytherapy involves delivering radiotherapy from inside the body by temporarily placing a tiny radioactive source directly into the tumor or other targeted area. Using a robotic device called an afterloader, clinicians place the radioactive source into positions through needles that have been inserted into the area being treated. The source is then moved within the needles under computer control to create the specified dose distribution within the patient's anatomy. 

Using the latest version of Vitesse, HDR brachytherapy treatment plans can be created in a real-time environment, using ultrasound images generated in the operating room rather than CT scans generated elsewhere. This avoids the need to move the patient to a CT scanner room for imaging after the needles have been put in place. The process can now be completed entirely within the Vitesse program, from capturing the ultrasound image to finalizing an approved treatment plan.

In addition to receiving FDA 510(k) clearance which permits sale of the Vitesse software in the United States, Varian has also obtained the CE Mark which permits sales in the European Union and other countries where the CE Mark is recognized.

日韩无码毛片